Skip to main content

People in the News: Feb 22, 2011

Premium

Affymetrix said this week that Paul Berg will retire from its board of directors in May. Berg has been a board member of the company since its inception in 1993.


Great Basin Corporation has hired Andrew Olson as vice president of sales. He most recently was vice president of sales and marketing at Signature Genomics, part of PerkinElmer.

Olson also held sales and marketing positions at Roche Diagnostics, BD GeneOhm, and Fisher Healthcare. He holds an MBA from the University of Houston and a BS in molecular biology from Brigham Young University.


Sigma-Aldrich has named Frank Wicks as president of research, replacing Dave Smoller, who will take over as chief scientific officer. The company also has promoted Gerrit van den Dool to be vice president and managing director of the firm's business in the US and Canada.

Wicks will be responsible for the Sigma-Aldrich's entire portfolio of research products, including its Research Essentials and Research Biotech businesses, Sigma said. Smoller will be charged with developing the company's global R&D strategy for all research initiatives, and with managing its IP portfolio and licensing activity. Van Den Dool formerly led North American sales and global accounts at the company.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.